Vactosertib and Durvalumab in Gastric Cancer

Clinical trial NCT04893252 · UNKNOWN

Trial details

NCT number: NCT04893252
Sponsor: Hark Kyun Kim
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasm

Start date: 2021-06-01
Primary completion: 2023-12-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.